Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Mar 04, 2020

SELL
$6.53 - $10.72 $97,950 - $160,800
-15,000 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$11.23 - $19.1 $5.5 Million - $9.36 Million
-490,000 Reduced 97.03%
15,000 $284,000
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $7.78 Million - $16.2 Million
505,000
505,000 $8.89 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track Francis Chou's Portfolio

Track Francis Chou Portfolio

Follow Francis Chou (Chou Associates Management Inc.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chou Associates Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chou Associates Management Inc. and Francis Chou with notifications on news.